Personal information

No personal information available

Activities

Employment (4)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology: Stuttgart, DE

2007-01 to present | Principal Investigator / Research group leader (Research Division Pharmacogenomics, Prof. M. Schwab)
Employment
Source: Self-asserted source
Oliver Burk

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology: Stuttgart, DE

2000-01 to 2006-12 | Principal Investigator / Research group leader (Research Division Pharmacogenomics, Prof. M. Eichelbaum)
Employment
Source: Self-asserted source
Oliver Burk

Robert Bosch Hospital: Stuttgart, DE

1997-10 to 1999-12 | Postdoctoral research fellow (Research group Prof. H. Wisser)
Employment
Source: Self-asserted source
Oliver Burk

Max-Planck-Institute of Immunobiology: Freiburg, DE

1993-05 to 1997-09 | Postdoctoral Research fellow (Research group PD Dr. K.-H. Klempnauer)
Employment
Source: Self-asserted source
Oliver Burk

Education and qualifications (5)

Justus Liebig Universitat Giessen: Giessen, Hessen, DE

1993-05-04 to 1993-05-04 | Dr. rer. nat. (Faculty of Biology)
Education
Source: Self-asserted source
Oliver Burk

Max-Planck-Institute of Immunobiology: Freiburg, DE

1990-06 to 1993-05 | PhD thesis (Research group PD DR. K.-H. Klempnauer)
Education
Source: Self-asserted source
Oliver Burk

Center of Molecular Biology (ZMBH): Heidelberg, DE

1989-09 to 1990-05 | PhD thesis (Research group PD Dr. K.-H. Klempnauer)
Education
Source: Self-asserted source
Oliver Burk

Justus Liebig Universitat Giessen: Giessen, Hessen, DE

1981-10 to 1987-08 | Study of Biology (Diploma)
Education
Source: Self-asserted source
Oliver Burk

Justus Liebig Universitat Giessen: Giessen, Hessen, DE

1986 to 1987 | Diploma Thesis (Dipl.-Biol.) (Institute of Genetics, Prof. F. Anders)
Education
Source: Self-asserted source
Oliver Burk

Funding (1)

Induction of drug-metabolizing enzymes and transporters in human intestine

1999-07 to 2003 | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
Source: Self-asserted source
Oliver Burk

Works (2)

Identification of novel agonists by high-throughput screening and molecular modelling of human constitutive androstane receptor isoform 3

Archives of Toxicology
2019-08-16 | Journal article
Contributors: Oliver Keminer; Björn Windshügel; Frank Essmann; Serene M. L. Lee; Tobias S. Schiergens; Matthias Schwab; Oliver Burk
Source: check_circle
Crossref

Human pregnane X receptor is activated by dibenzazepine carbamate-based inhibitors of constitutive androstane receptor

Archives of Toxicology
2017-06 | Journal article
Contributors: Judith Jeske; Björn Windshügel; Wolfgang E. Thasler; Matthias Schwab; Oliver Burk
Source: check_circle
Crossref